May 17 (Reuters) - A new diagnostic test from Veracyte Inc could help many people avoid risky and costly invasive lung biopsies at a time when millions of American smokers are eligible for lung cancer ...
Early diagnosis of lung cancer may improve the prognosis, but many people aren’t aware they have it until it spreads. Screening tests may help detect the disease. Blood tests are not yet available to ...
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today ...
CLEVELAND — November is Lung Cancer Awareness month. The disease is the leading cause of cancer death around the world, and according to the American Lung Association, nearly a quarter of a million ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest update is out from bioAffinity ...
Julie Harris had never been tested for lung cancer. A low-dose CT scan, the only recommended screening for adults at risk of developing lung cancer, was not something she’d ever found time to do. But ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. bioAffinity Technologies, Inc. ( (BIAF)) ...
An experimental blood test could one day help identify people most likely to develop severe lung problems like COPD. The test reviews a panel of 32 proteins in blood that best predict people most ...
A revolutionary AI-powered diagnostic test for chronic obstructive pulmonary disease (COPD) is set to be introduced in GP surgeries across England from 14 April, offering a faster and more accurate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback